Weber DM - Search Results

1

Outcomes of autologous stem cell transplantation in Waldenström's macroglobulinemia.

Saini NY, Patel RD, Varma A, Bashir Q, Delgado R, Rondon G, Mukherjee A, Popat U, Hosing C, Nieto Y, Kebriaei P, Weber DM, Thomas SK, Lee HC, Manasanch EE, Orlowski RZ, Champlin RE, Qazilbash MH, Patel KK. Saini NY, et al. Among authors: weber dm. Ann Hematol. 2019 Sep;98(9):2233-2235. doi: 10.1007/s00277-019-03734-7. Epub 2019 Jun 26. Ann Hematol. 2019. PMID: 31243571 No abstract available.

2

2Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine.

Dimopoulos MA, Weber DM, Kantarjian H, Keating M, Alexanian R. Dimopoulos MA, et al. Among authors: weber dm. Ann Oncol. 1994 Mar;5(3):288-9. doi: 10.1093/oxfordjournals.annonc.a058811. Ann Oncol. 1994. PMID: 7514439 Free article.

3

Intensive sequential therapy for VAD-resistant multiple myeloma.

Dimopoulos MA, Weber DM, Hester J, Delasalle K, Champlin R, Alexanian R. Dimopoulos MA, et al. Among authors: weber dm. Leuk Lymphoma. 1994 May;13(5-6):479-84. doi: 10.3109/10428199409049638. Leuk Lymphoma. 1994. PMID: 7915163 Clinical Trial.

4

2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia.

Weber DM, Dimopoulos MA, Delasalle K, Rankin K, Gavino M, Alexanian R. Weber DM, et al. Semin Oncol. 2003 Apr;30(2):243-7. doi: 10.1053/sonc.2003.50070. Semin Oncol. 2003. PMID: 12720145

5

166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials.

Giralt S, Bensinger W, Goodman M, Podoloff D, Eary J, Wendt R, Alexanian R, Weber D, Maloney D, Holmberg L, Rajandran J, Breitz H, Ghalie R, Champlin R. Giralt S, et al. Blood. 2003 Oct 1;102(7):2684-91. doi: 10.1182/blood-2002-10-3250. Epub 2003 May 1. Blood. 2003. PMID: 12730103 Free article. Clinical Trial.

6

High-dose topotecan, melphalan and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of multiple myeloma.

Donato ML, Aleman A, Champlin RE, Weber D, Alexanian R, Ippoliti CM, de Lima M, Anagnostopoulos A, Giralt S. Donato ML, et al. Leuk Lymphoma. 2004 Apr;45(4):755-9. doi: 10.1080/10428190310001603957. Leuk Lymphoma. 2004. PMID: 15160952 Clinical Trial.

7

Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma.

Anagnostopoulos A, Aleman A, Ayers G, Donato M, Champlin R, Weber D, Alexanian R, Giralt S. Anagnostopoulos A, et al. Cancer. 2004 Jun 15;100(12):2607-12. doi: 10.1002/cncr.20294. Cancer. 2004. PMID: 15197803 Free article.

8

Thalidomide-dexamethasone as primary therapy for advanced multiple myeloma.

Wang M, Weber DM, Delasalle K, Alexanian R. Wang M, et al. Among authors: weber dm. Am J Hematol. 2005 Jul;79(3):194-7. doi: 10.1002/ajh.20382. Am J Hematol. 2005. PMID: 15981221 Free article. Clinical Trial.

9

Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation.

Donato ML, Feasel AM, Weber DM, Prieto VG, Giralt SA, Champlin RE, Duvic M. Donato ML, et al. Among authors: weber dm. Blood. 2006 Jan 15;107(2):463-6. doi: 10.1182/blood-2004-12-4870. Epub 2005 Sep 22. Blood. 2006. PMID: 16179379 Free PMC article.

10

Risk factors for relapse after complete remission with high-dose therapy for multiple myeloma.

Qazilbash MH, Saliba RM, Aleman A, Lei X, Weber D, Carrasco A, Champlin RE, Giralt SA. Qazilbash MH, et al. Leuk Lymphoma. 2006 Jul;47(7):1360-4. doi: 10.1080/10428190500520806. Leuk Lymphoma. 2006. PMID: 16923569

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

234 results

Search Page